A Study on the Preference of Risperidone Dosage Forms

NCT06657430 · tracked via the Priya Life Science China tracker

Sponsor

Shanghai Mental Health Center

Phase

Observational

Started

2024-09-19

Last updated

2024-10-24

Condition(s) studied

SchizophreniaBipolar Affective DisorderAutism Spectrum DisorderConduct DisorderMental Retardation

Study summary

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study. Exclusion Criteria: * Have difficulty reading and understanding Chinese or refuse to participate in the study.

Primary outcome measure(s)

Proportion of patients (and their caregivers) who prefer risperidone patch-form medicine — "through study completion, an average of 6 months
The proportion of patients (and their caregivers) who preferred risperidone patch among the respondents in this study

Trial sites (1)

Facility	City	Region	Status
Shanghai Mental Health Center	Shanghai	Shanghai Municipality	Recruiting

More Shanghai Mental Health Center trials in China

Multi-target TMS for Schizophrenia Negative Symptoms Starting soon

Neural Mechanisms of Temporal Interference Stimulation on Improving Social Reward Function in Depression Recruiting

Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa Recruiting

Effect of High-Intensity Transcranial Alternating Current Stimulation on Gambling Disorder: A Randomized Controlled Trial Recruiting

Tracking Risk in Adolescents and Children for Early Identification of Common Mental Disorders Starting soon

Other trials for the same condition

Improving Quality of Informal Care for People With Schizophrenia Starting soon

Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study Recruiting

Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models Recruiting

NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia Recruiting

Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06657430 on ClinicalTrials.gov ↗ ← All trials in China